Skip to main content

Table 2 Spirometry results and COPD (n= 95)

From: Obstructive lung disease and quality of life after cure of multi-drug-resistant tuberculosis in Uganda: a cross-sectional study

Measure of lung function

Median (IQR) or N (%)

FEV1, L

2.1 (1.7, 2.6)

 FEV1 ≥ 80% of predicted

36 (38%)

 FEV1 50–79% of predicted

47 (49%)

 FEV1 30–49% of predicted

12 (13%)

 FEV1 < 30% of predicted

0 (0%)

FEV1 percent predicted

74.9 (62.4, 88.9)

FVC, L

2.9 (2.4, 3.3)

FVC percent predicted

81.9 (69.0, 89.8)

FEV1/FVC ratio

0.78 (0.70, 0.83)

FEV1/FVC ratio percent predicted

93.5 (84.1, 101.7)

FEV1/FVC < LLN

29 (31%)

FEV1/FVC < 0.70 (COPD)

22 (23%)

 FEV1 ≥ 80% of predicted

0 (0%)

 FEV1 50–79% of predicted

12 (55%)

 FEV1 30–49% of predicted

10 (45%)

 FEV1 < 30% of predicted

0 (0%)

  1. COPD chronic obstructive pulmonary disease, LLN lower limit of normal